There is no way the CEO of AHZ lined himself up blind for an hour n half preso not knowing the results. I don't believe that for one second. I believe they knew from their own internal testing what to expect and that the results would underwhelm. The 1.5hr slot was just for show to keep the SP rolling.
The fact that there was just constant selling and lack of traction even into the last FDA notice didn't sit right with a lot of us and now we know why. Shame on me for being fooled again by the ASX where there is just no integrity in anything.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-96
-
- There are more pages in this discussion • 255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.740(5.48%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.25 | $13.35 | $309.6K | 22.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1150 | $14.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.25 | 314 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |